Research programme: RNA therapeutics - Arpeggio biosciences
Alternative Names: RNA therapeutics: Arpeggio biosciencesLatest Information Update: 03 Mar 2023
At a glance
- Originator Arpeggio Biosciences
- Class Anti-inflammatories; Small molecules
- Mechanism of Action RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Autoimmune disorders; Inflammation
Most Recent Events
- 31 Jan 2023 Early research in Autoimmune disorders in USA (Parenteral) (Arpeggio Biosciences pipeline, January 2023)
- 31 Jan 2023 Early research in Inflammation in USA (Parenteral) (Arpeggio Biosciences pipeline, January 2023)